PMC News

PMC Suggests Guidances on Risk, CLIA Accompany LDT Framework

In its response letter to FDA on the agency's proposed framework for regulating laboratory-developed tests (LDTs), PMC suggests that the agency publish draft guidance documents on risk classification and Clinical Laboratory Improvement Amendments (CLIA) harmonization alongside a second draft of the original framework documents. » Download the Letter

PMC Joins Stakeholders for "Precision Medicine" Announcement
PMC's Amy Miller joined stakeholders at the White House on Jan. 30 when Obama announced his "Precision Medicine Initiative."» Watch the announcement